Copy reference, caption or embed code
Figure 1 - White Matter Disease as a Biomarker for Long-Term Cerebrovascular Disease and Dementia
![Figure 1. Severity of MRI-detected white matter hyperintensity. Total burden of white matter disease varies significantly among asymptomatic adults and patients with known cerebrovascular disease. In age-matched individuals, white matter hyperintensity (WMH) volume may vary from mild to very severe ( upper panel ). Using validated semi-automated volumetric protocol, WMH volume can be quantified ( lower panel , in red , WMH maps are derived from contiguous supratentorial axial T2-FLAIR MRI slices using previously published method [10]) with a high degree of accuracy and precision.](https://www.researchgate.net/profile/Aurauma-Chutinet/publication/260107838/figure/fig1/AS:297309255553024@1447895458284/Severity-of-MRI-detected-white-matter-hyperintensity-Total-burden-of-white-matter_Q320.jpg)
Severity of MRI-detected white matter hyperintensity. Total burden of white matter disease varies significantly among asymptomatic adults and patients with known cerebrovascular disease. In age-matched individuals, white matter hyperintensity (WMH) volume may vary from mild to very severe ( upper panel ). Using validated semi-automated volumetric protocol, WMH volume can be quantified ( lower panel , in red , WMH maps are derived from contiguous supratentorial axial T2-FLAIR MRI slices using previously published method [10]) with a high degree of accuracy and precision.
Reference
Caption
Embed code